Four Philippine Drug Makers Recall Drugs For Labels, Bacteria
This article was originally published in PharmAsia News
Cathay Drug, GlaxoSmithKline Philippines, Novartis Healthcare Philippines and Pfizer Consumer Healthcare said they would recall batches of their drugs from The Philippines market, either because of bacteria contamination or label mistakes.
You may also be interested in...
Claims circulated on social media that its Cebion supplement could prevent coronavirus has led Italy's Dompé to take legal action.
AbbVie’s latest, largest acquisition may be cast in a new light as the pandemic throws stock markets into turmoil and commercial prospects up in the air.
Smiths Medical is increasing paraPAC ventilator production from hundreds to thousands a month to fulfill 10,000 units as part of the Ventilator Challenge UK consortium.